Clinical Outcomes
We quantify perioperative and longitudinal outcomes including complications, neurological and functional recovery, readmissions, reoperations, length of stay, survival when relevant, and recovery trajectories.
We study how patients recover after neurosurgical care, why outcomes vary, and how clinical data can be transformed into evidence that supports better decisions.
We quantify perioperative and longitudinal outcomes including complications, neurological and functional recovery, readmissions, reoperations, length of stay, survival when relevant, and recovery trajectories.
We integrate the patient perspective through validated measures of pain, disability, quality of life, function, satisfaction, recovery and return to meaningful activities.
We develop and validate prognostic and risk models, with attention to calibration, external validation, missing data, clinical utility and transparent use of machine learning.
We study patterns of care, resource use, comparative effectiveness, quality, access and variation in practice to support safer and more efficient neurosurgical care.
We combine traditional clinical endpoints with neurological function, independence, quality of life and patient-reported recovery so that success reflects more than technical performance alone.
We examine patient characteristics, disease phenotype, treatment strategy, timing, complications and care pathways to understand the drivers of short- and long-term variation.
Comparative and longitudinal analyses are used to identify heterogeneous treatment effects and clinically relevant subgroups rather than relying only on population averages.
We evaluate whether prognostic models add information that is accurate, generalisable and useful at the point of care, with a strong emphasis on external validation and clinical interpretation.
Harmonised definitions, core outcome sets, longitudinal follow-up and data-quality procedures designed for collaborative research.
Validated instruments collected at clinically meaningful time points to capture pain, disability, function and quality of life.
Transparent model development, calibration, discrimination, internal and external validation, and evaluation of clinical utility.
Repeated-measures, time-to-event and trajectory approaches to understand recovery over time rather than at a single endpoint.
Observational causal methods and careful adjustment for case mix to compare strategies when randomised trials are not feasible.
Predefined variables, transparent reporting, versioned analyses and data structures designed to support validation across centres.
Traumatic brain injury, spinal cord injury and complex trauma pathways.
Degenerative disease, complex reconstruction and ankylosed-spine pathology.
Functional, patient-reported and treatment-pathway outcomes in brain tumours.
Frailty, functional reserve, cognition and patient-centred recovery in older adults.
Access, quality and outcomes across different health-system and resource settings.
Translational work linking biological signals, including the microbiome, with neurovascular phenotypes and clinical outcomes.
Our goal is not prediction for its own sake. We prioritise outcomes that matter to patients, methods that can be externally validated, and analyses that can meaningfully inform care.